Expert: Bicistronic CAR T targeting both CD19 and CD20 antigens to reduce antigen escape-driven relapse in B-cell lymphomas.

Everyday: Next-generation engineered immune cells that target two proteins on lymphoma cells simultaneously.

Targets: ["CD19","CD20"]